Organovo (ONVO) –
-
Organovo (ONVO) Announces Positive Phase 2 Results for FXR314 in MASH
-
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compare
-
Form S-1 ORGANOVO HOLDINGS, INC.
-
Form SC 13G/A ORGANOVO HOLDINGS, INC. Filed by: Nikko Asset Management Americas, Inc.
-
Form EFFECT ORGANOVO HOLDINGS, INC.
-
Form 424B5 ORGANOVO HOLDINGS, INC.
-
Form 10-Q ORGANOVO HOLDINGS, INC. For: Dec 31
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Feb 07
-
Form SC 13G/A ORGANOVO HOLDINGS, INC. Filed by: Sumitomo Mitsui Trust Holdings, Inc.
-
Organovo (ONVO) Files $150M Mixed Shelf
-
Form S-3 ORGANOVO HOLDINGS, INC.
-
Organovo (ONVO) Presents FXR314 3D Human Tissue Model Findings
-
Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
-
Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Dec 28
-
Form 424B5 ORGANOVO HOLDINGS, INC.
-
Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
-
Form S-8 ORGANOVO HOLDINGS, INC.
-
Form 4 ORGANOVO HOLDINGS, INC. For: Nov 17 Filed by: STERN ADAM K
-
Form 4 ORGANOVO HOLDINGS, INC. For: Nov 17 Filed by: Milhous Alison Tjosvold
-
Form 4 ORGANOVO HOLDINGS, INC. For: Nov 17 Filed by: Cohen Douglas Jay
-
Form 4 ORGANOVO HOLDINGS, INC. For: Nov 17 Filed by: Murphy Keith
-
Form 4 ORGANOVO HOLDINGS, INC. For: Nov 15 Filed by: Gobel David
-
Form 4 ORGANOVO HOLDINGS, INC. For: Nov 17 Filed by: Joshi Vaidehi
-
Form 144 ORGANOVO HOLDINGS, INC. Filed by: Gobel David
-
CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan
-
Form 10-Q ORGANOVO HOLDINGS, INC. For: Sep 30
-
Organovo (ONVO) Highlights FXR314 Combination Therapy Potential and Plan
-
Organovo Highlights FXR314 Combination Therapy Potential and Plan
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Oct 31
-
Form 8-K/A ORGANOVO HOLDINGS, INC. For: Aug 16
-
Form ARS ORGANOVO HOLDINGS, INC. For: Mar 31
-
Form DEFA14A ORGANOVO HOLDINGS, INC.
-
Form DEF 14A ORGANOVO HOLDINGS, INC. For: Oct 31
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Sep 07
-
Organovo to Participate in the H.C. Wainwright Global Investment Conference
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Aug 31
-
Organovo (ONVO) Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
-
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Aug 16
-
Form 10-Q ORGANOVO HOLDINGS, INC. For: Jun 30
-
Form 10-K/A ORGANOVO HOLDINGS, INC. For: Mar 31
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Jul 18
-
Form PRE 14A ORGANOVO HOLDINGS, INC. For: Sep 14
-
Form 10-K ORGANOVO HOLDINGS, INC. For: Mar 31
-
Form NT 10-K ORGANOVO HOLDINGS, INC. For: Mar 31
-
Organovo (ONVO) Announces FXR Program
-
Organovo Announces FXR Program
-
Organovo Announces FXR Program
-
Form 8-K ORGANOVO HOLDINGS, INC. For: Mar 10
Back to ONVO Stock Lookup